Patients with Hypercoagulability and Cerebral Infarction Caused by Covid-19

Corona Virus Disease 19 (COVID-19) plague is a deadly disease that gets the world's attention, also in Indonesia. The death cases report shows a high number with a sum of more than 95.723 in August 2021 and predicted the case will increase. The virus can cause cerebral edema which penetrates the brain through the olfactory epithelium and induces Cytokine Storm Syndrome (CSS) which can cause interference with the Blood-Brain Barrier (BBB) resulting in hypoxia and coagulopathy. This study used a case study approach with detail testing towards one event. In this case, cerebral infarction caused by COVID-19 was proven by laboratory results with symptoms of inflammation, CSF, sepsis, and coagulopathy. These symptoms can lead to cerebral infarction and hypercoagulability. Treatment interventions are carried out to reduce inflammation and cerebral edema and prevent secondary infection. COVID-19, in this case, is considered to have a deleterious effect on cerebral infarction patients. Proper treatments are needed to give better results.